Traws Pharma, Inc.
Develops oral small-molecule therapies for respiratory viral diseases and cancer.
TRAW | US
Overview
Corporate Details
- ISIN(s):
- US68232V8845 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 12 PENNS TRAIL, 18940 NEWTOWN
- Website:
- https://www.trawspharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company that develops novel, oral small-molecule therapies for respiratory viral diseases and cancer. The company focuses on advancing investigational antiviral agents with potent activity against difficult-to-treat or resistant virus strains. Its pipeline includes Ratutrelvir, a ritonavir-independent treatment targeting the main protease (Mpro) for COVID-19 and Long COVID, and Tivoxavir marboxil, a single-dose therapy targeting the cap-dependent endonuclease (CEN) for bird flu and seasonal influenza. Traws Pharma aims to develop safe product candidates with simple dosing regimens and utilizes accelerated clinical trial strategies for vulnerable patient populations.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Traws Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Traws Pharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Traws Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
